Delivery Order SPE2DB24D2205-SPE2DB25FDVAZ

Award Date 12/4/24
Potential Completion Date 12/5/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDVAZ
    Delivery Order

This federal contract award, valued at $1,226.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific product being delivered under this award is 4566609625 ISENTRESS 400 MG TABLET 60S. The contract has a firm fixed price pricing type and a completion date of December 5, 2024. This award was not designated as a set-aside contract, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply procurement programs.

Generated 3/5/25, 10:08 AM